hydroxyproline has been researched along with Bone Cancer in 178 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In 21 patients with breast cancer and TIO, we determined the biochemical effects of a single infusion of pamidronate given at 30 mg (n = 5), 60 mg (n = 5), 90 mg (n = 5), or 120 mg (n = 6)." | 9.08 | Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study. ( Body, JJ; Dumon, JC; Ford, J; Piccart, M, 1995) |
| "The superiority of pamidronate in controlling hypercalcemia is mirrored by the changes observed in these markers." | 9.08 | Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. ( Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J, 1997) |
| " Pamidronate disodium, a bisphosphonate, may prove helpful in the palliative treatment of bone metastases in patients with breast cancer as demonstrated in this multicenter, dose-ranging trial." | 9.07 | Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. ( Browning, S; Fram, RJ; George, S; Glover, D; Keller, A; Lipton, A; Macerata, RS; Miller, AA; Seaman, JJ; Zelenakas, K, 1994) |
| "The excretion of urinary hydroxyproline has been measured before mastectomy in 342 patients presenting with breast cancer for the first time to Guy's Hospital." | 7.67 | Urinary hydroxyproline and prognosis in human breast cancer. ( Grant, CS; Hayward, JL; Hoare, SA; Millis, RR; Wang, DY, 1984) |
| "The values of urinary hydroxyproline excretion reflecting the bone remodelling by osteoclasts, and the bone isoenzyme of serum alkaline phosphatase reflecting the osteoblastic function, in 100 randomly selected healthy subjects, 100 patients with primary hyperparathyroidism, and 100 patients with osteolytic secondary tumorous deposits in the skeleton showed a bivariate lognormal distribution." | 7.67 | Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism. ( Bek, V; Broulík, P; Mikulecký, M; Pacovský, V; Stĕpán, JJ, 1989) |
| "Breast cancer patients (n = 224) aged 28 to 81 were postoperatively followed up with serial determinations of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), and urinary hydroxyproline (OHP)." | 7.67 | A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. ( Carpi, A; Di Marco, G; Giordani, R; Giuliani, L; Nicolini, A; Palla, S, 1989) |
| "Serial estimations of the hydroxyproline (OHP) excretion during chemotherapy were performed in 24 women bearing advanced breast carcinoma with skeletal metastases." | 7.66 | [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases]. ( Fazzin, G; Maccari, F; Nascimben, O; Polico, C, 1978) |
| "The postabsorptive urinary hydroxyproline excretion test (Spot-HYPRO) was evaluated for its usefulness in reflecting the presence or absence of bone metastasis in 75 women with breast cancer." | 7.66 | The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer. ( McDonald, MW; Neely, CL; Niell, HB; Palmieri, GM, 1983) |
| "A significant correlation between the activity of the bone isoenzyme or serum alkaline phosphatase and the urinary hydroxyproline excretion in osteomalacia, osteoporosis, primary hyperparathyroidism with osteodystrophy, Paget's disease, secondary bone tumours, and in a control group was found (P less than 0." | 7.66 | Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases. ( Formánková, J; Horn, V; Hrba, J; Konopásek, B; Marek, J; Pacovský, V; Silinková-Málková, E; Stĕpán, J; Vokrouhlická, O, 1978) |
| "Postabsorptive urine hydroxyproline (HYPRO) excretion ("spot" HYPRO test) was compared with the 24-hour urine excretion of HYPRO in 45 patients with breast cancer and nine normal subjects on a low-gelatin diet." | 7.66 | Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer. ( McDonald, MW; Neely, CL; Niell, HB; Palmieri, GM, 1981) |
| "Urinary hydroxyproline was elevated significantly in patients with untreated stage D prostatic carcinoma when compared to values in patients with benign prostatic hypertrophy and prostatic carcinoma without bony metastasis." | 7.66 | Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate. ( Kim, H; Mooppan, MM; Tobin, MS; Wang, JC; Wax, SH, 1980) |
| " We therefore assessed the effect of Indomethacin and aspirin on some parameters of calcium metabolism in patients with breast cancer." | 7.65 | Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. ( Bondy, PK; Coombes, RC; Neville, AM; Powles, TJ, 1976) |
| "The hydroxyproline/creatinine excretion ratios have been measured in half-hour fasting morning urine specimens from breast cancer patients and compared with corresponding values measured in 24 hour urine collections." | 7.65 | Early morning hydroxyproline excretion in patients with breast cancer. ( Bondy, PK; Leese, CL; Powles, TJ; Rosset, G, 1976) |
| "In 181 consecutive patients with breast cancer, urinary hydroxyproline excretion has been critically evaluated in conjunction with clinical, biochemical, radiological and scintigraphic parameters." | 7.65 | Relevance of hydroxyproline excretion to bone metastasis in breast cancer. ( Dequeker, J; Drochmans, A; Gielen, F; Merlevede, M; Wildiers, J, 1976) |
| "21 patients had bone metastases diagnosed by bone scanning (99mTc MDP)." | 5.26 | Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma. ( Bishop, MC; Fellows, GJ, 1977) |
| "Patient's with carcinoma metastases in bone and Pagent's disease of bone have different patterns of collagen metabolite excretion." | 5.26 | Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone. ( Kelleher, PC, 1979) |
| "Patients with skeletal metastases (n = 24) showed significantly higher hydroxyproline excretion in the urine than did those with prostate cancer without metastases, or healthy men of the same age (n = 35)." | 5.26 | Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases. ( Bichler, KH; Harzmann, R; Heller, W; Schmidt, K, 1979) |
| "When surgery fails to cure breast cancer it is due to disseminated micrometastases present at the time of operation." | 5.26 | Hydroxyproline excretion in the detection of occult bone metastases from breast cancer. ( Banks, AJ; Morrison, MJ; Roginski, C; Rowse, AD; Scott, PH, 1982) |
| "15 patients with breast cancer and proven bone metastases have been studied." | 5.26 | [Hydroxyproline in the diagnosis of bone metastases in breast cancer]. ( Alberto, P; Courvoisier, B; Depierre, D; Gasser, AB, 1977) |
| " In 21 patients with breast cancer and TIO, we determined the biochemical effects of a single infusion of pamidronate given at 30 mg (n = 5), 60 mg (n = 5), 90 mg (n = 5), or 120 mg (n = 6)." | 5.08 | Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study. ( Body, JJ; Dumon, JC; Ford, J; Piccart, M, 1995) |
| "The superiority of pamidronate in controlling hypercalcemia is mirrored by the changes observed in these markers." | 5.08 | Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. ( Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J, 1997) |
| " Pamidronate disodium, a bisphosphonate, may prove helpful in the palliative treatment of bone metastases in patients with breast cancer as demonstrated in this multicenter, dose-ranging trial." | 5.07 | Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. ( Browning, S; Fram, RJ; George, S; Glover, D; Keller, A; Lipton, A; Macerata, RS; Miller, AA; Seaman, JJ; Zelenakas, K, 1994) |
| " Eight of these patients had either hypercalcemia or hypercalciuria, and all 10 had elevated urinary hydroxyproline levels as evidence of active skeletal disease." | 5.05 | Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton. ( Canfield, RE; Hyman, GA; Siris, ES, 1983) |
| "Amine-carboxyboranes have been shown to prevent osteoporosis and loss of bone mass in rodents." | 3.69 | The anti-osteoporotic activity of amine-carboxyboranes in rodents. ( Chen, SY; Hall, IH; Rajendran, KG; Sood, A; Spielvogel, BF, 1995) |
| " We compared several new markers of bone turnover in normocalcaemic patients with breast cancer-induced osteolysis before and after a single infusion of the bisphosphonate pamidronate." | 3.69 | Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy. ( Body, JJ; Delmas, PD; Dumon, JC; Gineyts, E, 1997) |
| "We evaluated the serum osteocalcin and alkaline phosphatase levels and the urinary hydroxyproline excretion in patients with blastic, lithic or mixed metastases, humoral malignant hypercalcemia (HMH) and myeloma." | 3.68 | [Bone turnover markers in tumor pathology with bone involvement]. ( Amado Señarís, JA; González Macías, J; Napal Lecumberri, J; Pesquera, C; Riancho, JA, 1990) |
| "The excretion of urinary hydroxyproline has been measured before mastectomy in 342 patients presenting with breast cancer for the first time to Guy's Hospital." | 3.67 | Urinary hydroxyproline and prognosis in human breast cancer. ( Grant, CS; Hayward, JL; Hoare, SA; Millis, RR; Wang, DY, 1984) |
| "The values of urinary hydroxyproline excretion reflecting the bone remodelling by osteoclasts, and the bone isoenzyme of serum alkaline phosphatase reflecting the osteoblastic function, in 100 randomly selected healthy subjects, 100 patients with primary hyperparathyroidism, and 100 patients with osteolytic secondary tumorous deposits in the skeleton showed a bivariate lognormal distribution." | 3.67 | Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism. ( Bek, V; Broulík, P; Mikulecký, M; Pacovský, V; Stĕpán, JJ, 1989) |
| "Breast cancer patients (n = 224) aged 28 to 81 were postoperatively followed up with serial determinations of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), and urinary hydroxyproline (OHP)." | 3.67 | A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. ( Carpi, A; Di Marco, G; Giordani, R; Giuliani, L; Nicolini, A; Palla, S, 1989) |
| "Thirty-three patients with multiple myeloma were studied with serial skeletal surveys, serum immunoglobulin levels, and postabsorptive urinary hydroxyproline (Spot-HYPRO) determinations." | 3.67 | Skeletal surveys in multiple myeloma. Radiologic-clinical correlation. ( Niell, HB; Palmieri, GM; Reidy, TJ; Sebes, JI, 1986) |
| "The postabsorptive urinary hydroxyproline excretion test (Spot-HYPRO) was evaluated for its usefulness in reflecting the presence or absence of bone metastasis in 75 women with breast cancer." | 3.66 | The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer. ( McDonald, MW; Neely, CL; Niell, HB; Palmieri, GM, 1983) |
| "Postabsorptive urine hydroxyproline (HYPRO) excretion ("spot" HYPRO test) was compared with the 24-hour urine excretion of HYPRO in 45 patients with breast cancer and nine normal subjects on a low-gelatin diet." | 3.66 | Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer. ( McDonald, MW; Neely, CL; Niell, HB; Palmieri, GM, 1981) |
| "The authors study the daily elimination of hydroxyproline in breast cancer with and without roentgenological or radioisotopic bone scanning evidence of bone lesion." | 3.66 | [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer]. ( Espinós Pérez, D; Millán Núñez-Cortés, J; Rico Lenza, H; Rodríguez Mora, VI, 1980) |
| "Seventy-one patients with breast cancer and bone metastases, together with other assessable sites of disease, were monitored by radiologic skeletal survey, bone scanning, pain charts, bone marrow aspirate, serum calcium, alkaline phosphatase and urine hydroxyproline/creatinine ratio." | 3.66 | Assessment of response of bone metastases to systemic treatment in patients with breast cancer. ( Coombes, RC; Dady, P; Ford, HT; Gazet, JC; McCready, VR; Parsons, C; Powles, TJ, 1983) |
| "Urinary hydroxyproline was elevated significantly in patients with untreated stage D prostatic carcinoma when compared to values in patients with benign prostatic hypertrophy and prostatic carcinoma without bony metastasis." | 3.66 | Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate. ( Kim, H; Mooppan, MM; Tobin, MS; Wang, JC; Wax, SH, 1980) |
| "A significant correlation between the activity of the bone isoenzyme or serum alkaline phosphatase and the urinary hydroxyproline excretion in osteomalacia, osteoporosis, primary hyperparathyroidism with osteodystrophy, Paget's disease, secondary bone tumours, and in a control group was found (P less than 0." | 3.66 | Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases. ( Formánková, J; Horn, V; Hrba, J; Konopásek, B; Marek, J; Pacovský, V; Silinková-Málková, E; Stĕpán, J; Vokrouhlická, O, 1978) |
| "The urinary excretion of Hydroxyproline (OH-P), evaluated as OH-P/creatinine ratio, has been examined in the follow up of 142 breast cancer patients." | 3.66 | [Hydroxyprolinuria and bone metastases of breast cancer]. ( Bardella, D; Cruciani, G; Fiorentini, GM; Marangolo, M; Tavolazzi, L, 1980) |
| "The Authors have studied total urinary hydroxyproline (TUH), together with other hematochemical analyses, in 104 patients suffering from advanced breast cancer with or without bone metastases." | 3.66 | [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses]. ( Biagi, R; Colalongo, G; Jafelice, G; Mambelli, M; Martoni, A; Pannuti, F; Pedelini, G; Piana, E; Rocchetta, G, 1980) |
| "Serial estimations of the hydroxyproline (OHP) excretion during chemotherapy were performed in 24 women bearing advanced breast carcinoma with skeletal metastases." | 3.66 | [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases]. ( Fazzin, G; Maccari, F; Nascimben, O; Polico, C, 1978) |
| " We therefore assessed the effect of Indomethacin and aspirin on some parameters of calcium metabolism in patients with breast cancer." | 3.65 | Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. ( Bondy, PK; Coombes, RC; Neville, AM; Powles, TJ, 1976) |
| "The hydroxyproline/creatinine excretion ratios have been measured in half-hour fasting morning urine specimens from breast cancer patients and compared with corresponding values measured in 24 hour urine collections." | 3.65 | Early morning hydroxyproline excretion in patients with breast cancer. ( Bondy, PK; Leese, CL; Powles, TJ; Rosset, G, 1976) |
| "In 181 consecutive patients with breast cancer, urinary hydroxyproline excretion has been critically evaluated in conjunction with clinical, biochemical, radiological and scintigraphic parameters." | 3.65 | Relevance of hydroxyproline excretion to bone metastasis in breast cancer. ( Dequeker, J; Drochmans, A; Gielen, F; Merlevede, M; Wildiers, J, 1976) |
| "A rapid and significant suppression of bone resorption was observed in all patients after intravenous treatment." | 2.69 | Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton. ( Hamdy, NA; Lycklama à Nijeholt, AA; Papapoulos, SE; Pelger, RC; Zwinderman, AH, 1998) |
| "Biochemical markers of bone resorption and bone formation are abnormally raised in the blood and urine of patients with metastatic bone disease." | 2.41 | Biochemical markers and skeletal metastases. ( Costa, L; Demers, LM; Lipton, A, 2000) |
| "Markers of bone resorption are sensitive to changes in bone turnover induced by treatment." | 2.41 | Markers of bone turnover in bone metastases. ( Delmas, PD; Fontana, A, 2000) |
| "Alendronate failed to inhibit MMP-2 activity directly, but instead appeared to block cellular secretion of MMP-2." | 1.30 | Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells. ( Stearns, ME, 1998) |
| "Hydroxyproline was also measured." | 1.29 | Biochemical markers for detecting bone metastases in patients with breast cancer. ( Crivellari, D; de Bernard, B; Galligioni, E; Gazzarrini, C; Moro, L; Talamini, R, 1993) |
| "The present open study included 16 prostate cancer patients who had painful bone metastases and who had failed hormonal therapy." | 1.29 | The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer. ( Kylmälä, T; Lindholm, TS; Seppänen, J; Tammela, TL, 1994) |
| " We propose as a working hypothesis a classification of responses taking into account the criteria: the urinary hydroxyproline to urinary creatinine ratio, the serum dosage of bone isoenzyme of alkaline phosphatase and propeptide of type III procollagen (P III NP), and as an essential element, an analysis of all available imaging techniques." | 1.28 | [Response of bone metastases to medical treatment: definition of evaluation criteria and classification trials]. ( Belpomme, D; Bock, P; Cappelaere, P; Droz, JP; Marie, FN; Namer, M; Pecking, A; Rouesse, J; Tan, TN; Vanel, D, 1989) |
| "Biochemical evaluation showed that bone resorption from metastatic disease was generally not enough to account for hypercalcaemia." | 1.27 | Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. ( Boyle, IT; Fogelman, I; Gardiner, MD; Ralston, SH, 1984) |
| "Thirty-two men with stage D2 prostatic cancer were monitored by bone scan, acid and alkaline phosphatase values, and urinary hydroxyproline, beginning from 4 to 36 months after initiation of hormonal manipulation and/or systemic chemotherapy." | 1.27 | Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. ( Hopkins, SC; Ikard, M; Moinuddin, M; Nissenkorn, I; Palmieri, GM; Soloway, MS, 1983) |
| "Both were elevated in patients with prostatic cancer with active bone metastases compared to the values of prostatic cancer without bone metastasis and benign prostatic hypertrophy." | 1.27 | [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)]. ( Imai, K; Kitaura, K; Kurokawa, K; Tomaru, Y; Yamanaka, H, 1985) |
| "Increases without any evidence of metastases are either due to other diseases with connective tissue changes or to occult micrometastases." | 1.27 | [The value of the free hydroxyproline and the N-acetyl-beta- glucosaminidase for the observation of the course of malignant tumors]. ( Lange, H; Müller, A; Ruffert, K, 1986) |
| "In metastatic prostate cancer where blastic osseous metastases predominate, disease progression on bone scan correlated with elevation of both total hydroxyproline excretion (7." | 1.27 | Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer. ( Hopkins, SC; Moinuddin, M; Niell, HB; Palmieri, GM; Soloway, MS, 1984) |
| "In patients with prostatic cancer--the ones with bone metastases proved by bone scanning--urinary HOP levels were found to be 69." | 1.27 | Urinary hydroxyproline levels in patients with prostatic carcinoma. ( Adalar, N; Erol, D; Güvençli, S; Simşek, F, 1983) |
| "In patients with osteolytic lesions from multiple myeloma, elevated T and D levels with normal ND HYPRO values were observed, along with elevated D/ND ratios." | 1.27 | Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer. ( Hopkins, SC; Maxwell, TA; Neely, CL; Niell, HB; Palmieri, GM; Soloway, MS, 1983) |
| " It is concluded that PIP activity dosage in serum may provide with urinary hydroxyproline, further information for the study of collagen metabolism in osteoblastic bone diseases during treatment." | 1.27 | [Determination of serum proline iminopeptidase activity using a fluorescent substrate in patients with Paget's disease and prostatic bone metastases. Preliminary results]. ( Bouvier, M; Colson, F; Mathieu, M; Tebib, J; Vianey-Liaud, C, 1986) |
| "Treatment with gallium nitrate for five to seven days caused a median reduction in 24-hour urinary calcium excretion of 66% relative to baseline measurements (P less than ." | 1.27 | Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases. ( Alcock, NW; Bockman, RS; Warrell, RP, 1987) |
| "Patients with skeletal metastases (n = 24) showed significantly higher hydroxyproline excretion in the urine than did those with prostate cancer without metastases, or healthy men of the same age (n = 35)." | 1.26 | Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases. ( Bichler, KH; Harzmann, R; Heller, W; Schmidt, K, 1979) |
| "Patients with breast cancer may show an increased requirement for thiamin particularly when treated with 5-fluorouracil, and a number of metabolic disturbances in which ascorbic acid may play a central role." | 1.26 | Nutrition and breast cancer. ( Dickerson, JW, 1979) |
| "15 patients with breast cancer and proven bone metastases have been studied." | 1.26 | [Hydroxyproline in the diagnosis of bone metastases in breast cancer]. ( Alberto, P; Courvoisier, B; Depierre, D; Gasser, AB, 1977) |
| "21 patients had bone metastases diagnosed by bone scanning (99mTc MDP)." | 1.26 | Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma. ( Bishop, MC; Fellows, GJ, 1977) |
| "The development of human tumors is accompanied very often by tumor-associated phenomena such as production of tumor-derived substances, production of certian substances in response to the tumor or immunological reactions." | 1.26 | Biological markers of human tumors and monitoring of cancer treatment. ( Nissen, E; Tanneberger, S; Ziegenbein, R, 1979) |
| "In 25 patients with prostatic cancer and 26 patients with benign prostatic hypertrophy, urinary hydroxyproline excretion as estimated by the method described by Cleary and Saunders." | 1.26 | Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer. ( Aoyagi, K; Rinsho, K, 1982) |
| "Those who had marrow metastasis produced elevated levels of hydroxyproline; the highest excretions were observed when marrow fibrosis was associated with metastasis." | 1.26 | Urinary hydroxyproline excretion in myelofibrosis. ( Aung, MK; Tobin, MS; Wang, JC, 1980) |
| "When surgery fails to cure breast cancer it is due to disseminated micrometastases present at the time of operation." | 1.26 | Hydroxyproline excretion in the detection of occult bone metastases from breast cancer. ( Banks, AJ; Morrison, MJ; Roginski, C; Rowse, AD; Scott, PH, 1982) |
| "It is increased in cases of metastatic cancer of bone." | 1.26 | An automatic technique for the routine fractionation of the urinary hydroxyproline containing peptides. ( Borel, JP; Garbe, A; Joubert, PM; Randoux, A; Szymanovicz, A, 1980) |
| "Patient's with carcinoma metastases in bone and Pagent's disease of bone have different patterns of collagen metabolite excretion." | 1.26 | Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone. ( Kelleher, PC, 1979) |
| "Of 31 patients with prostatic cancer, 21 have skeletal metastases proven by bone scintigraphy and/or radiology." | 1.26 | [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer]. ( Courvoisier, B; Depierre, D; Gasser, AB; Jeannet, C, 1981) |
| "Lytic activity of eosinophilic granuloma and other tumours was studied in vitro on collagen substrate." | 1.26 | Collagenolytic activity of eosinophilic granuloma in vitro. ( Barbey, S; Bazin, S; Mouly, H; Nezelof, C; Rousseau-Merck, MF, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 154 (86.52) | 18.7374 |
| 1990's | 22 (12.36) | 18.2507 |
| 2000's | 2 (1.12) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RUBEGNI, M | 1 |
| RAVENNI, G | 1 |
| DEL GIOVANE, L | 1 |
| KLEIN, L | 1 |
| LAFFERTY, FW | 1 |
| PEARSON, OH | 1 |
| CURTISS, PH | 1 |
| Platt, WD | 1 |
| Doolittle, LH | 1 |
| Hartshorn, JW | 1 |
| LEE, CA | 2 |
| LLOYD, HM | 2 |
| AVIOLI, LV | 1 |
| MCDONALD, JE | 1 |
| SINGER, RA | 1 |
| Takahashi, Y | 1 |
| Matsuo, M | 1 |
| Inoue, H | 1 |
| Raab, W | 5 |
| Schwägerl, W | 2 |
| Borel, JP | 3 |
| Caranjot, JM | 1 |
| Jayle, MF | 1 |
| Nakagawa, M | 1 |
| Sugiura, Y | 1 |
| Oshima, T | 2 |
| Kajino, G | 1 |
| Hirako, H | 1 |
| Waalkes, TP | 2 |
| Abeloff, MD | 1 |
| Ettinger, DS | 1 |
| Woo, KB | 1 |
| Gehrke, CW | 1 |
| Mrochek, JE | 1 |
| Schulze, G | 1 |
| Rinsho, K | 3 |
| Unni Mooppan, MM | 1 |
| Kim, H | 2 |
| Wang, JC | 3 |
| Tobin, MS | 3 |
| Wax, SH | 2 |
| Siris, ES | 3 |
| Hyman, GA | 1 |
| Canfield, RE | 3 |
| Coombes, RC | 5 |
| Dearnaley, DP | 1 |
| Buckman, R | 1 |
| Jones, JM | 1 |
| Ormerod, MG | 1 |
| Sloane, JP | 2 |
| Powles, TJ | 7 |
| Gazet, JC | 4 |
| Ford, HT | 4 |
| Neville, AM | 3 |
| Deeble, TJ | 1 |
| Goldberg, DM | 1 |
| Ralston, SH | 1 |
| Fogelman, I | 1 |
| Gardiner, MD | 1 |
| Boyle, IT | 1 |
| Jacobs, TP | 2 |
| Bilezikian, JP | 1 |
| Baquiran, DC | 1 |
| Shane, E | 1 |
| Dady, PJ | 1 |
| Smith, IE | 1 |
| Parsons, CA | 1 |
| Henk, JM | 2 |
| Nash, AG | 2 |
| Skalková, D | 1 |
| Romics, I | 2 |
| Lengyel, L | 1 |
| Nemoto, S | 1 |
| Niell, HB | 5 |
| Neely, CL | 3 |
| Palmieri, GM | 6 |
| McDonald, MW | 2 |
| Maxwell, TA | 1 |
| Hopkins, SC | 3 |
| Soloway, MS | 3 |
| Sanz Ortiz, J | 1 |
| Mayo Suárez, J | 1 |
| Riancho Moral, JA | 1 |
| Amado Señarís, JA | 2 |
| Erol, D | 1 |
| Adalar, N | 1 |
| Güvençli, S | 1 |
| Simşek, F | 1 |
| Bellido, V | 1 |
| Carda, P | 1 |
| Mascías, E | 1 |
| Moinuddin, M | 2 |
| Grant, CS | 1 |
| Hoare, SA | 1 |
| Millis, RR | 1 |
| Hayward, JL | 1 |
| Wang, DY | 1 |
| Kelleher, PC | 2 |
| Smith, CJ | 1 |
| Nissenkorn, I | 1 |
| Ikard, M | 1 |
| Dady, P | 1 |
| Parsons, C | 1 |
| McCready, VR | 1 |
| Hirano, H | 1 |
| Urist, MR | 1 |
| Tormey, DC | 1 |
| Gasser, AB | 4 |
| Depierre, D | 4 |
| Mermillod, B | 1 |
| Courvoisier, B | 7 |
| Adamo, V | 1 |
| Altavilla, G | 1 |
| La Torre, F | 1 |
| Palmara, D | 1 |
| Tropea, F | 1 |
| Rowse, AD | 1 |
| Morrison, MJ | 1 |
| Scott, PH | 1 |
| Banks, AJ | 1 |
| Roginski, C | 1 |
| Aoyagi, K | 1 |
| Rico Lenza, H | 1 |
| Millán Núñez-Cortés, J | 1 |
| Rodríguez Mora, VI | 1 |
| Espinós Pérez, D | 1 |
| Jeannet, C | 1 |
| Pemp, W | 1 |
| Feustel, A | 1 |
| Bower, L | 2 |
| Manley, G | 2 |
| Budavári, I | 1 |
| Kisbenedek, L | 1 |
| Balogh, F | 1 |
| Szymanovicz, A | 1 |
| Joubert, PM | 1 |
| Garbe, A | 1 |
| Randoux, A | 2 |
| Aung, MK | 1 |
| Mooppan, MM | 1 |
| Martoni, A | 1 |
| Pedelini, G | 1 |
| Colalongo, G | 1 |
| Biagi, R | 1 |
| Mambelli, M | 1 |
| Jafelice, G | 1 |
| Rocchetta, G | 1 |
| Piana, E | 1 |
| Pannuti, F | 1 |
| Cruciani, G | 1 |
| Bardella, D | 1 |
| Fiorentini, GM | 1 |
| Marangolo, M | 1 |
| Tavolazzi, L | 1 |
| Miyamoto, KK | 1 |
| McSherry, SA | 1 |
| Robins, SP | 1 |
| Besterman, JM | 1 |
| Mohler, JL | 1 |
| Plosker, GL | 1 |
| Goa, KL | 1 |
| Alcover, J | 1 |
| Fernández-Conde, M | 1 |
| Filella, X | 1 |
| de Osaba, MJ | 1 |
| Carretero, P | 1 |
| Glover, D | 1 |
| Lipton, A | 2 |
| Keller, A | 1 |
| Miller, AA | 1 |
| Browning, S | 1 |
| Fram, RJ | 1 |
| George, S | 1 |
| Zelenakas, K | 1 |
| Macerata, RS | 1 |
| Seaman, JJ | 1 |
| Kylmälä, T | 1 |
| Tammela, TL | 1 |
| Lindholm, TS | 1 |
| Seppänen, J | 1 |
| Rajendran, KG | 1 |
| Chen, SY | 1 |
| Sood, A | 1 |
| Spielvogel, BF | 1 |
| Hall, IH | 1 |
| O'Rourke, N | 1 |
| McCloskey, E | 1 |
| Houghton, F | 1 |
| Huss, H | 1 |
| Kanis, JA | 4 |
| Mazières, B | 2 |
| Laroche, M | 1 |
| Cantagrel, A | 1 |
| Wada, S | 1 |
| Katayama, Y | 1 |
| Yasutomo, Y | 1 |
| Kugai, N | 1 |
| Nagata, N | 1 |
| Taube, T | 1 |
| Elomaa, I | 1 |
| Blomqvist, C | 1 |
| Beneton, MN | 1 |
| Moro, L | 1 |
| Gazzarrini, C | 1 |
| Crivellari, D | 1 |
| Galligioni, E | 1 |
| Talamini, R | 1 |
| de Bernard, B | 1 |
| Body, JJ | 3 |
| Dumon, JC | 2 |
| Piccart, M | 1 |
| Ford, J | 1 |
| Vinholes, J | 1 |
| Guo, CY | 1 |
| Purohit, OP | 1 |
| Eastell, R | 1 |
| Coleman, RE | 1 |
| Gineyts, E | 1 |
| Delmas, PD | 2 |
| Pelger, RC | 1 |
| Hamdy, NA | 1 |
| Zwinderman, AH | 1 |
| Lycklama à Nijeholt, AA | 1 |
| Papapoulos, SE | 1 |
| Stearns, ME | 1 |
| Kołaczkowska, M | 1 |
| Junik, R | 1 |
| Rzymkowska, M | 1 |
| Kramer, L | 1 |
| Demers, LM | 1 |
| Costa, L | 1 |
| Fontana, A | 1 |
| Tanneberger, S | 1 |
| Nissen, E | 1 |
| Ziegenbein, R | 1 |
| Stĕpán, J | 2 |
| Pacovský, V | 2 |
| Horn, V | 1 |
| Silinková-Málková, E | 1 |
| Vokrouhlická, O | 1 |
| Konopásek, B | 2 |
| Formánková, J | 1 |
| Hrba, J | 1 |
| Marek, J | 1 |
| Harzmann, R | 2 |
| Bichler, KH | 2 |
| Dickerson, JW | 2 |
| Heller, W | 1 |
| Schmidt, K | 1 |
| Pust, R | 1 |
| Rost, A | 1 |
| Weidner, W | 1 |
| Rothauge, CF | 1 |
| Rousseau-Merck, MF | 1 |
| Barbey, S | 1 |
| Mouly, H | 1 |
| Bazin, S | 1 |
| Nezelof, C | 1 |
| Mundy, AR | 1 |
| Bishop, MC | 1 |
| Fellows, GJ | 1 |
| Anson, A | 1 |
| Cuschieri, A | 5 |
| Jarvie, R | 1 |
| Taylor, WH | 1 |
| Cant, E | 1 |
| Furnival, CM | 1 |
| Blumgart, LH | 1 |
| Ambanelli, U | 1 |
| Ferraccioli, GF | 1 |
| Bernardi, P | 1 |
| Servemti, G | 1 |
| Polico, C | 1 |
| Nascimben, O | 1 |
| Maccari, F | 1 |
| Fazzin, G | 1 |
| Burkhardt, H | 5 |
| Wepler, R | 2 |
| Rommel, K | 5 |
| Hillyard, CJ | 1 |
| Thomas, P | 1 |
| Keyser, JW | 1 |
| Marcus, D | 1 |
| Zinberg, N | 1 |
| Stimson, WH | 1 |
| Alberto, P | 1 |
| Balaba, TIa | 1 |
| Furtseva, LN | 1 |
| Nefed'eva, NN | 1 |
| Gielen, F | 1 |
| Dequeker, J | 1 |
| Drochmans, A | 1 |
| Wildiers, J | 1 |
| Merlevede, M | 1 |
| Rosset, G | 1 |
| Leese, CL | 2 |
| Bondy, PK | 3 |
| Roberts, JG | 2 |
| Baum, M | 3 |
| Burkhardt, F | 1 |
| Williams, M | 1 |
| Bligh, AS | 1 |
| Szymanowicz, A | 1 |
| Malgras, A | 1 |
| Cosson, R | 1 |
| Roques, CF | 1 |
| Amigues, H | 1 |
| Fournie, A | 1 |
| Arlet, J | 1 |
| Ruffié, R | 1 |
| Rotstein, S | 1 |
| Glas, U | 1 |
| Eriksson, M | 1 |
| Pfeiffer, P | 1 |
| Hansen, J | 1 |
| Söderqvist, J | 1 |
| Bandmann, U | 1 |
| Strid, S | 1 |
| Zysset, E | 1 |
| Ammann, P | 1 |
| Jenzer, A | 1 |
| Gertz, BJ | 1 |
| Portmann, L | 1 |
| Rizzoli, R | 1 |
| Jaquet-Müller, F | 1 |
| Pryor-Tillotson, S | 1 |
| Bonjour, JP | 1 |
| Burckhardt, P | 1 |
| Clarke, NW | 1 |
| McClure, J | 1 |
| George, NJ | 1 |
| Takenaka, I | 1 |
| Miyagawa, I | 1 |
| Kunitomi, K | 1 |
| Hirakawa, S | 1 |
| Matsuoka, N | 1 |
| Kawamura, H | 1 |
| Napal Lecumberri, J | 1 |
| Pesquera, C | 1 |
| Riancho, JA | 1 |
| González Macías, J | 1 |
| Kurokawa, K | 1 |
| Imai, K | 1 |
| Yamanaka, H | 1 |
| Tomaru, Y | 1 |
| Kitaura, K | 1 |
| Ruffert, K | 1 |
| Müller, A | 1 |
| Lange, H | 1 |
| Teshima, T | 1 |
| Chatani, M | 1 |
| Inoue, T | 1 |
| Hirokawa, Y | 1 |
| Wadasaki, K | 1 |
| Kasiwado, K | 1 |
| Kagemoto, M | 1 |
| Katsuta, S | 1 |
| Honke, Y | 1 |
| Koyama, T | 1 |
| Nicolini, A | 1 |
| Carpi, A | 1 |
| Di Marco, G | 1 |
| Giuliani, L | 1 |
| Giordani, R | 1 |
| Palla, S | 1 |
| Belpomme, D | 1 |
| Droz, JP | 1 |
| Marie, FN | 1 |
| Namer, M | 2 |
| Tan, TN | 1 |
| Pecking, A | 1 |
| Rouesse, J | 1 |
| Vanel, D | 1 |
| Bock, P | 1 |
| Cappelaere, P | 1 |
| Stĕpán, JJ | 1 |
| Mikulecký, M | 1 |
| Bek, V | 2 |
| Broulík, P | 1 |
| Attardo-Parrinello, G | 1 |
| Merlini, G | 1 |
| Pavesi, F | 1 |
| Crema, F | 1 |
| Fiorentini, ML | 1 |
| Ascari, E | 1 |
| Urwin, GH | 1 |
| Percival, RC | 2 |
| Yates, AJ | 2 |
| Watson, ME | 1 |
| Couch, M | 1 |
| McDonald, B | 1 |
| Forrest, AR | 1 |
| Williams, JL | 1 |
| Borkowski, A | 1 |
| Cleeren, A | 1 |
| Bijvoet, OL | 1 |
| Godsall, JW | 1 |
| Burtis, WJ | 1 |
| Insogna, KL | 1 |
| Broadus, AE | 1 |
| Stewart, AF | 1 |
| Sebes, JI | 1 |
| Reidy, TJ | 1 |
| O'Brien, WM | 1 |
| Lynch, JH | 1 |
| Kawamura, J | 1 |
| Tochigi, H | 1 |
| Yanagawa, M | 1 |
| Yoshida, O | 1 |
| Hida, S | 1 |
| Mori, O | 1 |
| Suzuki, N | 1 |
| Saito, K | 1 |
| Komatsu, Y | 1 |
| Hatayama, T | 1 |
| Conte, N | 1 |
| Di Virgilio, R | 1 |
| Roiter, I | 1 |
| Caberlotto, L | 1 |
| Francini, G | 1 |
| Bigazzi, S | 1 |
| Leone, V | 1 |
| Gennari, C | 1 |
| Scher, HI | 1 |
| Curley, T | 1 |
| Geller, N | 1 |
| Dershaw, D | 1 |
| Chan, E | 1 |
| Nisselbaum, J | 1 |
| Alcock, N | 1 |
| Hollander, P | 1 |
| Yagoda, A | 1 |
| Frenay, M | 1 |
| Boublil, JL | 1 |
| Khater, R | 1 |
| Viot, M | 1 |
| François, E | 1 |
| Milano, G | 1 |
| Bouvier, M | 1 |
| Colson, F | 1 |
| Tebib, J | 1 |
| Mathieu, M | 1 |
| Vianey-Liaud, C | 1 |
| Hausner, P | 1 |
| Kolár, J | 1 |
| Vosecký, M | 1 |
| Nový, F | 1 |
| Janko, L | 1 |
| Knorr, A | 1 |
| Engelmann, U | 1 |
| Gross, C | 1 |
| Friedrich, S | 1 |
| Serdengeçti, S | 1 |
| Serdengeçti, K | 1 |
| Derman, U | 1 |
| Berkarda, B | 1 |
| Warrell, RP | 1 |
| Alcock, NW | 1 |
| Bockman, RS | 1 |
| Stevens, MJ | 1 |
| Charhon, SA | 1 |
| Chapuy, MC | 1 |
| Delvin, EE | 1 |
| Meunier, PJ | 1 |
| Althoff, J | 1 |
| Quint, P | 1 |
| Höhling, HJ | 1 |
| Roessner, A | 1 |
| Grundmann, E | 1 |
| Gray, RE | 1 |
| Galloway, J | 1 |
| Rogers, K | 1 |
| Neal, FE | 1 |
| Morii, H | 2 |
| Tanae, A | 1 |
| Ibayashi, H | 1 |
| Nakao, K | 1 |
| Maeda, H | 1 |
| Radom, S | 3 |
| Zulawski, M | 3 |
| Golebiowska, D | 1 |
| Lejeune, E | 1 |
| Meunier, P | 1 |
| Ruitton, P | 1 |
| Orgiazzi, J | 1 |
| Kontturi, MJ | 1 |
| Sotaniemi, EA | 1 |
| Larmi, TK | 1 |
| Freiberg, RA | 1 |
| Air, GW | 1 |
| Glueck, CJ | 1 |
| Ishikawa, T | 1 |
| Abrams, NR | 1 |
| Manner, G | 1 |
| Kuleba, M | 1 |
| Parsons, V | 2 |
| Dalley, V | 1 |
| Brinkley, D | 1 |
| Davies, C | 1 |
| Vernon, A | 1 |
| Matsushita, Y | 1 |
| Hasegawa, K | 1 |
| Sugimura, R | 1 |
| Otomo, S | 1 |
| Basu, TK | 2 |
| Donaldson, D | 1 |
| Williams, DC | 2 |
| Raven, RW | 1 |
| Dahlig, E | 1 |
| Drozdz, M | 1 |
| Kucharz, E | 1 |
| Sumner, DS | 1 |
| Edwards, MH | 1 |
| Aho, AJ | 1 |
| Einola, S | 1 |
| Paasio, J | 1 |
| Zender, R | 3 |
| Niejadlik, DC | 1 |
| Felgate, RA | 1 |
| Felgate, R | 1 |
| Klimmt, G | 1 |
| Sári, P | 1 |
| Uhlich, F | 1 |
| Sienczewska-Burzyńska, J | 1 |
| Jaruga-Dolińska, E | 1 |
| Ogane, S | 1 |
| Gruson, M | 1 |
| Ryckewaert, A | 1 |
| Hioco, D | 1 |
| Lanham, C | 1 |
| de Sèze, S | 1 |
| Kocher, P | 1 |
| Anyanwu, G | 2 |
| Endres, O | 2 |
| Dietrich, M | 1 |
| Czitober, H | 2 |
| Kriegel, W | 1 |
| Langness, U | 1 |
| Jahn, P | 1 |
| Yamada, Y | 1 |
| Carbone, PP | 1 |
| Zipkin, I | 1 |
| Sokoloff, L | 1 |
| Frazier, P | 1 |
| Cook, P | 1 |
| Mullins, F | 1 |
| Mirejovská, E | 1 |
| Beska, F | 1 |
| Pitronová, M | 1 |
| Kerkhoff, JF | 1 |
| Ditzel, J | 2 |
| Jordal, R | 2 |
| Riskoer, N | 1 |
| Riskaer, N | 1 |
| Guzzo, CE | 1 |
| Pachas, WN | 1 |
| Pinals, RS | 1 |
| Krant, MJ | 1 |
| Hosley, HF | 1 |
| Taft, EG | 1 |
| Olson, KB | 1 |
| Gates, S | 1 |
| Beebe, RT | 1 |
| Bonadonna, G | 1 |
| Merlino, MJ | 1 |
| Myers, WP | 1 |
| Sonenberg, M | 1 |
| Mühlbach, R | 2 |
| Hirthe, D | 1 |
| Lindenhayn, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for hydroxyproline and Bone Cancer
| Article | Year |
|---|---|
Collagen metabolites in the urine and serum of patients with cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Collagen; Colorimetry; Female; Humans; Hydroxylysine; Hydroxyproli | 1982 |
Biological markers as prognostic and clinical evaluation tools.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Chorionic Gonadotropin; Creatinine; Fema | 1980 |
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose | 1994 |
Biochemical markers and skeletal metastases.
Topics: Alkaline Phosphatase; Biomarkers; Bone Development; Bone Neoplasms; Bone Resorption; Humans; Hydroxy | 2000 |
Markers of bone turnover in bone metastases.
Topics: Alkaline Phosphatase; Biomarkers; Bone Development; Bone Neoplasms; Bone Resorption; Collagen; Human | 2000 |
[Indications for urinary hydroxyproline determination].
Topics: Arthritis, Rheumatoid; Bone Neoplasms; Hodgkin Disease; Humans; Hydroxyproline; Neoplasm Metastasis; | 1976 |
Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
Topics: Adenylyl Cyclases; Alkaline Phosphatase; Animals; Bone Neoplasms; Calcium; Cyclic AMP; Disease Model | 1986 |
[Urinary excretion of hydroxyproline as an index of systemic collagen metabolism].
Topics: Adult; Age Factors; Body Surface Area; Bone and Bones; Bone Diseases; Bone Neoplasms; Calcinosis; Ch | 1972 |
18 trials available for hydroxyproline and Bone Cancer
| Article | Year |
|---|---|
Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
Topics: Administration, Oral; Adult; Aged; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clini | 1983 |
Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trial | 1982 |
Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Analgesics, Opioid; Bone Neoplasms; Bre | 1994 |
Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Neo | 1995 |
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcitonin; Calcium; | 1993 |
Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.
Topics: Adult; Aged; Analysis of Variance; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcitriol; Ca | 1995 |
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Neoplasms; Bone Resorption; Calcium; C | 1997 |
Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Bone Neo | 1998 |
[The effect of chemotherapy on bone metabolism in patients with non-small cell lung cancer].
Topics: Adult; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; B | 1998 |
Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Bone Neoplasms; Breast Neoplasms; Calcium; Clodronic | 1992 |
Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Neoplasms; Bone Resorption; Calcium; Diphosphonates; Doub | 1992 |
Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.
Topics: Alkaline Phosphatase; Bone Neoplasms; Bone Resorption; Calcium; Creatinine; Diphosphonates; Humans; | 1992 |
[A multiinstitutional prospective randomized study of radiation therapy of bone metastasis. II. Prognostic factors].
Topics: Bone Neoplasms; Creatinine; Humans; Hydroxyproline; Lung Neoplasms; Multicenter Studies as Topic; Pr | 1989 |
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 1987 |
Dichloromethylene diphosphonate action in hematologic and other malignancies.
Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Tr | 1987 |
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnover.
Topics: Adenocarcinoma; Aged; Bone and Bones; Bone Neoplasms; Bone Resorption; Calcium; Clinical Trials as T | 1987 |
Salmon calcitonin in the treatment of bone metastases.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcitonin; Calcium; Female; Follow-Up Studies; H | 1986 |
Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Circadian Rhythm; Clinical Trials as Topic; Female; H | 1972 |
152 other studies available for hydroxyproline and Bone Cancer
| Article | Year |
|---|---|
[Increase of urinary elimination of hydroxyproline in osteolytic processes].
Topics: Bone Neoplasms; Breast Neoplasms; Humans; Hydroxyproline; Male; Neoplasm Metastasis; Prostatic Neopl | 1962 |
CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Calcium; Geri | 1964 |
URINARY HYDROXYPROLINE EXCRETION IN METASTATIC CANCER OF BONE.
Topics: Acid Phosphatase; Biomedical Research; Bone Neoplasms; Breast Neoplasms; Collagen; Humans; Hydroxypr | 1964 |
URINARY HYDROXYPROLINE IN DISEASES INVOLVING BONE AND CALCIUM METABOLISM.
Topics: Acute Kidney Injury; Alkaline Phosphatase; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Calcium; | 1964 |
EXCRETION OF PYROPHOSPHATE IN DISORDERS OF BONE METABOLISM.
Topics: Bone Neoplasms; Bone Resorption; Chromatography; Diphosphates; Fluids and Secretions; Humans; Hydrox | 1965 |
[Urinary hydroxy-proline in patients with urolithiasis].
Topics: Bone Neoplasms; Decalcification, Pathologic; Fractures, Bone; Humans; Hydroxyproline; Hyperparathyro | 1966 |
[Hydroxyproline excretion in the urine in destructive bone processes].
Topics: Adolescent; Adult; Bone and Bones; Bone Diseases; Bone Neoplasms; Collagen; Female; Humans; Hydroxyp | 1967 |
[A method of fractionating urinary peptides containing hydroxyproline].
Topics: Acromegaly; Arthritis, Rheumatoid; Bone Neoplasms; Chemistry, Clinical; Chromatography, Ion Exchange | 1967 |
Urinary hydroxyproline excretion in orthopedic disease, with special reference to systemic bone disease and bone tumor (secondary report).
Topics: Adolescent; Adult; Bone Diseases; Bone Neoplasms; Child; Female; Humans; Hydroxyproline; Male | 1967 |
Multiple biological markers and breast carcinoma: a preliminary study in the detection of recurrent disease after primary therapy.
Topics: Aminoisobutyric Acids; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Creatinine; Femal | 1981 |
[Clinical value of enzyme parameter combinations in the diagnosis of metastases].
Topics: Acid Phosphatase; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Female; gamma-Glutamyltran | 1983 |
[Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer].
Topics: Aged; Bone Neoplasms; Humans; Hydroxyproline; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Ne | 1983 |
Use of urinary hydroxyproline excretion as a tumor marker in diagnosis and follow-up of prostatic carcinoma.
Topics: Bone Neoplasms; Castration; Creatinine; Estrogens; Follow-Up Studies; Humans; Hydroxyproline; Male; | 1983 |
Detection of bone metastases in patients with breast cancer.
Topics: Biopsy, Needle; Bone and Bones; Bone Marrow Examination; Bone Neoplasms; Breast Neoplasms; Diphospho | 1982 |
Assessment of biochemical tests for bone and liver involvement in malignant lymphoma patients.
Topics: Adult; Alkaline Phosphatase; Bone Neoplasms; Female; Humans; Hydroxyproline; Liver Neoplasms; Lympho | 1980 |
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
Topics: Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Carcinoma, Bronchogenic; | 1984 |
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Diarrhea; Diphosphonates; Dru | 1981 |
Use of an antiosteolytic agent in treatment of patients with bone metastases from breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Calcium; Doxorubicin; Drug Therapy, Combination; Fema | 1980 |
[Biochemical diagnosis of bone metastases].
Topics: Bone Neoplasms; Clinical Enzyme Tests; Humans; Hydroxyproline; Minerals | 1984 |
Study of serum and urine hydroxyproline level of patients with prostatic cancer.
Topics: Aged; Bone Neoplasms; Humans; Hydroxyproline; Male; Middle Aged; Prostatic Neoplasms | 1984 |
[Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer (II): Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and tumor markers in blood and urine].
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Creatine; Humans; Hydroxyproline; Male; | 1984 |
The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Middle Aged; Radiogra | 1983 |
Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Collagen; Dialysis; Female; Hodgkin Disease; Humans; Hydroxyprolin | 1983 |
[Value of the determination of urinary hydroxyproline in the detection of bone metastases].
Topics: Adult; Aged; Bone Neoplasms; Female; Humans; Hydroxyproline; Male; Middle Aged; Radiography | 1983 |
Urinary hydroxyproline levels in patients with prostatic carcinoma.
Topics: Aged; Bone Neoplasms; Humans; Hydroxyproline; Male; Middle Aged; Prostatic Neoplasms | 1983 |
[Urinary hydroxyproline and cancer of the breast].
Topics: Bone Neoplasms; Breast Neoplasms; Creatinine; Female; Humans; Hydroxyproline | 1983 |
Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Collagen; Creatinine; Dialysis; Humans; Hydroxyproline; Male; Neopla | 1984 |
Urinary hydroxyproline and prognosis in human breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Creatinine; Female; Humans; Hydroxyproline; Middle Ag | 1984 |
[Hydroxyproline and bone metastases].
Topics: Bone Neoplasms; Humans; Hydroxyproline | 1984 |
Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer.
Topics: Acid Phosphatase; Adenocarcinoma; Alkaline Phosphatase; Bone Neoplasms; Creatinine; Humans; Hydroxyp | 1983 |
Assessment of response of bone metastases to systemic treatment in patients with breast cancer.
Topics: Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Bone Marrow; Bone Neoplasms; Breast | 1983 |
Characteristics of the newly derived human chondrosarcoma cell line OSHU-1: observations on osteoinduction.
Topics: Animals; Bone Neoplasms; Cell Line; Chondrosarcoma; Humans; Hydroxyproline; Male; Mice; Mice, Nude; | 1980 |
[Effects of synthetic salmon calcitonin in the treatment of bone lesions of the neoplastic type].
Topics: Adult; Aged; Alkaline Phosphatase; Animals; Bone Neoplasms; Calcitonin; Calcium; Female; Humans; Hyd | 1982 |
Hydroxyproline excretion in the detection of occult bone metastases from breast cancer.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Creatinine; Evaluation Studies as Topic; Female; H | 1982 |
Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Topics: Bone Neoplasms; Creatinine; Humans; Hydroxyproline; Male; Prostatic Neoplasms | 1982 |
[Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Middle Aged | 1980 |
[Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcium; Creatinine; Humans; Hydroxypr | 1981 |
[Serum hydroxyproline parameter of collagen metabolism (author's transl)].
Topics: Adult; Aged; Arthritis, Rheumatoid; Bone Diseases; Bone Neoplasms; Collagen; Hip Prosthesis; Humans; | 1981 |
Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Creatinine; Female; Gelatin; Humans; Hydroxyproline | 1981 |
[Modern developments in the diagnosis and therapy of prostatic cancer].
Topics: Acid Phosphatase; Age Factors; Bone Neoplasms; Cyclophosphamide; Estrogens; Humans; Hydroxyproline; | 1981 |
Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Topics: Aged; Bone Neoplasms; Creatinine; Female; Glycosaminoglycans; Humans; Hydroxyproline; Male; Middle A | 1981 |
Study of hydroxyproline excretion in patients with prostatic cancer.
Topics: Bone Neoplasms; Humans; Hydroxyproline; Male; Prostatic Neoplasms | 1981 |
An automatic technique for the routine fractionation of the urinary hydroxyproline containing peptides.
Topics: Adolescent; Adult; Autoanalysis; Bone Neoplasms; Chemical Fractionation; Child; Female; Humans; Hydr | 1980 |
Urinary hydroxyproline excretion in myelofibrosis.
Topics: Bone Neoplasms; Collagen; Fibroblasts; Humans; Hydroxyproline; Neoplasm Metastasis; Neoplasms; Prima | 1980 |
Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate.
Topics: Bone Neoplasms; Carcinoma; Humans; Hydroxyproline; Male; Neoplasm Staging; Prostatic Neoplasms | 1980 |
[Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Medroxyprogesterone; | 1980 |
[Hydroxyprolinuria and bone metastases of breast cancer].
Topics: Bone Neoplasms; Breast Neoplasms; Creatinine; Female; Follow-Up Studies; Humans; Hydroxyproline | 1980 |
Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
Topics: Aged; Amino Acids; Biomarkers, Tumor; Bone Neoplasms; Circadian Rhythm; Collagen; Creatinine; Humans | 1994 |
[Correlation between bone gammagraphy and biochemical parameters in bone turnover in patients with prostate cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Creatinine; Humans; Hydroxyproline; | 1994 |
The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Neoplasms; Bone Resorption; Clodronic Acid; Dose | 1994 |
The anti-osteoporotic activity of amine-carboxyboranes in rodents.
Topics: Animals; Bone Neoplasms; Boranes; Calcium; Female; Hydroxyproline; In Vitro Techniques; Male; Mice; | 1995 |
[Biphosphonates and multiple myeloma].
Topics: Animals; Bone Neoplasms; Calcium; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Multiple My | 1993 |
Changes of bone metabolic markers in patients with bone metastases: clinical significance in assessing bone response to chemotherapy.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biom | 1993 |
Biochemical markers for detecting bone metastases in patients with breast cancer.
Topics: Alkaline Phosphatase; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neo | 1993 |
Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
Topics: Adult; Aged; Amino Acids; Analysis of Variance; Biomarkers; Bone Neoplasms; Bone Resorption; Breast | 1997 |
Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells.
Topics: Alendronate; Antineoplastic Agents; Bone Neoplasms; Collagen; Gelatinases; Humans; Hydroxyproline; M | 1998 |
Biological markers of human tumors and monitoring of cancer treatment.
Topics: Alkaline Phosphatase; alpha-Fetoproteins; Bone Neoplasms; Carcinoembryonic Antigen; Choriocarcinoma; | 1979 |
Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases.
Topics: Acromegaly; Adult; Alkaline Phosphatase; Bone Diseases; Bone Neoplasms; Female; Humans; Hydroxyproli | 1978 |
[Current status of diagnosis and stage classification of prostatic carcinoma].
Topics: Aged; Biopsy, Needle; Bone Neoplasms; Humans; Hydroxyproline; Lymphatic Metastasis; Male; Middle Age | 1977 |
Nutrition and breast cancer.
Topics: Animals; Ascorbic Acid; Bone Neoplasms; Breast Neoplasms; Calcium; Dietary Fats; Feeding Behavior; F | 1979 |
Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
Topics: Bone Neoplasms; Collagen; Glycosides; Humans; Hydroxylysine; Hydroxyproline; Neoplasm Metastasis; Os | 1979 |
Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases.
Topics: Bone Neoplasms; Humans; Hydroxyproline; Male; Neoplasm Metastasis; Prostatic Neoplasms; Radiography | 1979 |
[Evaluation of hydroxyproline excretion in the urine (UHP) in prostate carcinoma].
Topics: Aged; Bone Neoplasms; Carcinoma; Castration; False Negative Reactions; False Positive Reactions; Hum | 1979 |
Total urinary and free serum hydroxyproline in metastatic bone disease.
Topics: Adult; Aged; Bone Neoplasms; Creatinine; Female; Humans; Hydroxyproline; Male; Middle Aged; Neoplasm | 1979 |
Collagenolytic activity of eosinophilic granuloma in vitro.
Topics: Bone Neoplasms; Cells, Cultured; Child; Collagen; Eosinophilic Granuloma; Humans; Hydroxyproline | 1979 |
Urinary hydroxyproline excretion in carcinoma of the prostate. A comparison of 4 different modes of assessment and its role as a marker.
Topics: Aged; Bone Neoplasms; Creatinine; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Pros | 1979 |
Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcium; Creatinine; Humans; Hydroxypr | 1977 |
Urinary excretion of glycosaminoglycans in disseminated neoplasm.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Creatinine; Female; Glycosaminoglycans; Hexosamin | 1978 |
Three-centre study on urinary hydroxyproline excretion in cancer of the breast.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Methods; Middle Aged; | 1978 |
Relation between urine zinc and hydroxyproline in rheumatoid arthritis and bone diseases.
Topics: Arthritis, Rheumatoid; Bone Neoplasms; Humans; Hydroxyproline; Neoplasm Metastasis; Osteitis Deforma | 1978 |
[Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline | 1978 |
Urinary hydroxyproline in the management of breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Castration; Diethylstilbestrol; Female; Humans; Hydroxyproline; Ne | 1977 |
A biochemical approach to the staging of human breast cancer.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; C-Reactive Protein; Calcitonin; | 1977 |
[Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Creatinine; False Negative Reactions; Female; Humans; | 1977 |
[Collagen metabolism in children and adolescents with diseases of the skeletal system].
Topics: Adolescent; Adult; Bone Diseases; Bone Neoplasms; Child; Child, Preschool; Collagen; Female; Humans; | 1977 |
Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Female; Hu | 1976 |
Early morning hydroxyproline excretion in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Creatine; Female; Humans; Hydroxyproline; Neoplasm Metastasis; Tim | 1976 |
Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
Topics: Aspirin; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hype | 1976 |
Hydroxyproline excretion in patients with breast cancer and response to treatment.
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Ethinyl Estradiol; Female; Humans; | 1975 |
Letter: Predictive value of hydroxyproline: creatinine ratio in advanced breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Creatinine; Female; Humans; Hydroxyproline; Neoplasm Metastasis; R | 1975 |
[Diagnosis of bone metastases with special reference to the methods of clinical chemistry].
Topics: Alkaline Phosphatase; Bone Neoplasms; Calcium; Humans; Hydroxyproline; Methods; Neoplasm Metastasis; | 1975 |
The hypronosticon test in breast cancer.
Topics: Adult; Aged; Body Surface Area; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Creatinine; Female | 1975 |
A column chromatography fractionation of the hydroxyproline-containing urinary peptides with continuous automatic detection.
Topics: Autoanalysis; Bone Neoplasms; Chemical Fractionation; Chromatography; Chromatography, Gel; Chromatog | 1975 |
[Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Amino Acids; Bone Diseases; Bone Neoplasms; Calcitoni | 1976 |
[Clinical evaluation of bone turnover in patients with bone metastasis of various cancer of urogenital tract].
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Calcifediol; Calcium; Hu | 1990 |
[Bone turnover markers in tumor pathology with bone involvement].
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Neoplasms; Female; Humans; Hydro | 1990 |
[Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Topics: Bone Neoplasms; Humans; Hydroxyproline; Male; Prostatic Hyperplasia; Prostatic Neoplasms | 1985 |
[The value of the free hydroxyproline and the N-acetyl-beta- glucosaminidase for the observation of the course of malignant tumors].
Topics: Acetylglucosaminidase; Bone Neoplasms; Breast Neoplasms; Female; Hexosaminidases; Hodgkin Disease; H | 1986 |
A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Follow-U | 1989 |
[Response of bone metastases to medical treatment: definition of evaluation criteria and classification trials].
Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Evaluation Studies as Top | 1989 |
Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Breast N | 1989 |
Biochemical markers and skeletal metabolism in carcinoma of the prostate. Use of decision matrix theory and ROC analysis.
Topics: 6-Ketoprostaglandin F1 alpha; Bone and Bones; Bone Neoplasms; Calcium; Calcium-Binding Proteins; Hum | 1985 |
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Calcium; Cyclic AMP; Diphosphonates; Female; Head and | 1986 |
Skeletal surveys in multiple myeloma. Radiologic-clinical correlation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Humans; Hydroxyproline; Immu | 1986 |
Hydroxyproline as a marker for following patients with metastatic prostate cancer.
Topics: Bone Neoplasms; Buserelin; Creatinine; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; | 1988 |
[Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Calcium; Drug Evaluat | 1988 |
Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
Topics: Adult; Aged; Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Human | 1985 |
Serum osteocalcin concentration in patients with prostatic cancer.
Topics: 1-Carboxyglutamic Acid; Acid Phosphatase; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, | 1988 |
Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
Topics: Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies | 1988 |
[Determination of serum proline iminopeptidase activity using a fluorescent substrate in patients with Paget's disease and prostatic bone metastases. Preliminary results].
Topics: Adult; Aminopeptidases; Bone Neoplasms; Coumarins; Female; Humans; Hydroxyproline; Male; Middle Aged | 1986 |
[Comprehensive diagnostic approaches to tumor metastases in the skeleton. V. The relation of biochemical indicators to age in the diagnosis of bone metastases of stage II carcinoma of the breast. Analysis of additional diagnostic and prognostic parameters
Topics: Age Factors; Alkaline Phosphatase; Analysis of Variance; Bone Neoplasms; Breast Neoplasms; Carcinoma | 1987 |
[Detection of bone metastases using hydroxyproline excretion].
Topics: Bone Neoplasms; Humans; Hydroxyproline | 1986 |
Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases.
Topics: Adult; Aged; Antineoplastic Agents; Bone Development; Bone Neoplasms; Bone Resorption; Calcium; Fema | 1987 |
Efficacy of aminohydroxypropylidene diphosphonate in the treatment of malignancy-associated hypercalcaemia.
Topics: Adenosine Diphosphate; Bone Neoplasms; Breast Neoplasms; Calcium; Drug Evaluation; Female; Humans; H | 1987 |
Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Calcifediol; Calcitriol; Calcium; Humans; Hydroxyproline | 1985 |
Biological characterization of human bone tumors. V. Zonal characterization of osteosarcoma: topological biochemical analysis correlated with morphology.
Topics: Acid Phosphatase; Alkaline Phosphatase; Bone Neoplasms; Collagen; Glucuronidase; Hexosamines; Humans | 1985 |
Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Topics: Absorption; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Female; Humans; Hydroxyproline; H | 1985 |
[The clinical significance of urinary hydroxyproline determinations (author's transl)].
Topics: Alkaline Phosphatase; Animals; Arthritis, Rheumatoid; Bone Diseases; Bone Neoplasms; Burns; Carbon R | 1972 |
Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia.
Topics: Adenocarcinoma; Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcitonin; Calcium; Child, Presc | 1971 |
[Urinary pyrophosphate and hydroxyproline in bone tumors].
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Bone Neoplasms; Carcinoma 256, Walker; Child; Child, | 1969 |
Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Carcinoma, Intraductal, Noninfiltra | 1972 |
[Urinary hydroxyproline correlated with quantitative bone histological data. Attempted physiopathological interpretation].
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Diseases; Bone Neoplasms; Bone Resorption; Humans | 1972 |
Hydroxyproline in the early diagnosis of bone metastases in prostatic cancer.
Topics: Administration, Oral; Aged; Bone Neoplasms; Diethylstilbestrol; Humans; Hydroxyproline; Injections, | 1974 |
Multiple intraosseous lipomas with type-IV hyperlipoproteinemia. A case report.
Topics: Amino Acids; Ankle; Blood Protein Disorders; Bone Neoplasms; Cholesterol; Female; Glycosaminoglycans | 1974 |
Effect of dibutyryl-cyclic AMP on collagen and non-collagen protein synthesis in cultured human cells.
Topics: Adult; Animals; Bone and Bones; Bone Neoplasms; Bucladesine; Butyrates; Carbon Radioisotopes; Cattle | 1974 |
The effects of calcitonin on the metabolic disturbances surrounding widespread bony metastases.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Bronchial Neoplasms; Calcitonin | 1974 |
Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
Topics: Acid Phosphatase; Alkaline Phosphatase; Bone Neoplasms; Calcitonin; Calcium; Hexestrol; Humans; Hydr | 1974 |
Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Female; Humans; Hydroxyprolin | 1974 |
Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastases.
Topics: Ascorbic Acid; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Leukocytes; Male; N | 1974 |
'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Methods; Neoplasm Metastasis; Radi | 1973 |
Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; | 1973 |
Role of strontium (85Sr) scintigraphy in the clinical analysis of bone diseases.
Topics: Adult; Aged; Bone and Bones; Bone Diseases; Bone Neoplasms; Female; Fractures, Bone; Humans; Hydroxy | 1973 |
[Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
Topics: Alkaline Phosphatase; Bone and Bones; Bone Diseases; Bone Neoplasms; Calcium; Humans; Hydroxyproline | 1972 |
Hydroxyproline.
Topics: Bone and Bones; Bone Diseases; Bone Neoplasms; Burns; Collagen; Collagen Diseases; Fibrous Dysplasia | 1972 |
Urinary hydroxyproline excretion in carcinoma of the breast.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Creatinine; Female; Humans; Hydroxyproline; Middle Aged; Ne | 1972 |
Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; Co | 1971 |
Urinary hydroxyproline excretion in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Hydroxyproline; Neoplasm Metastasis | 1971 |
[Multiple enchondromatosis].
Topics: Bone Neoplasms; Child; Diagnosis, Differential; Humans; Hydroxyproline; Male; Osteochondrodysplasias | 1971 |
[Creatinine-hydroxyproline index in healthy subjects, in hyperthyroidism and in bone neoplasms].
Topics: Adult; Aged; Bone Neoplasms; Creatinine; Female; Graves Disease; Humans; Hydroxyproline; Hyperthyroi | 1971 |
[Total urinary hydroxyproline excretion in bone tumors].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Collagen; Female; Humans; Hydroxyproline; Male; Middle Age | 1967 |
Studies on urinary hydroxyproline.
Topics: Adolescent; Adult; Aged; Bone Diseases; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Hyd | 1969 |
[Correlation of hydroxyprolinuria and other parameters of bone metabolism].
Topics: Bone and Bones; Bone Diseases; Bone Neoplasms; Collagen; Humans; Hydroxyproline; Osteoporosis | 1970 |
[Urinary hydroxyproline during secondary bone cancers].
Topics: Bone Neoplasms; Humans; Hydroxyproline; Urine | 1966 |
[Study of urinary hydroxyproline in osteopathies].
Topics: Acromegaly; Adult; Aged; Bone Neoplasms; Female; Humans; Hydroxyproline; Hyperparathyroidism; Hypert | 1966 |
[Measurement of collagen catabolism in the diagnosis of bone metastases and in the evaluation of therapeutic success].
Topics: Adult; Aged; Bone Neoplasms; Collagen; Diethylstilbestrol; Female; Humans; Hydroxyproline; Male; Mid | 1969 |
[Plasma free amino acids in malignant bone tumors and in healthy subjects].
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Amino Acids; Bone Neoplasms; Calcium; Chromatography; | 1970 |
[Diagnosis of osseous involvement in Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Collagen; Female; Hodgkin Disease; Humans; Hydroxyproline; | 1970 |
[Hydroxyproline in generalized bone diseases].
Topics: Bone Diseases; Bone Neoplasms; Humans; Hydroxyproline; Male; Middle Aged; Neoplasm Metastasis | 1970 |
["Collagen-like protein" (CLP) and collagen antibodies in the serum of chronic polyarthritis and non-rheumatic diseases of connective tissue].
Topics: Aged; Antibodies; Antibody Specificity; Arthritis, Rheumatoid; Bone Neoplasms; Chronic Disease; Coll | 1970 |
[Investigation on urinary hydroxyproline--influence of skin collagen on urinary hydroxyproline and its adjustment by hydroxyproline--creatinine ratio].
Topics: Adolescent; Adult; Age Factors; Animals; Bone Neoplasms; Child; Child, Preschool; Collagen; Creatini | 1970 |
[Urinary hydroxyproline excretion in generalized bone diseases].
Topics: Adult; Aged; Alkaline Phosphatase; Arthritis, Rheumatoid; Bone Diseases; Bone Neoplasms; Female; Hum | 1967 |
Fluoride effect on bone in plasma cell myeloma.
Topics: Bone and Bones; Bone Neoplasms; Calcium; Cyclophosphamide; Fluorides; Humans; Hydroxyproline; Ilium; | 1968 |
The significance of hydroxyprolinuia for the proof of bone metastases of tumours.
Topics: Bone Neoplasms; Breast Neoplasms; Humans; Hydroxyproline; Lung Neoplasms; Neoplasm Metastasis; Radio | 1968 |
A rapid serum screening test for increased osteoblastic activity.
Topics: Adolescent; Adult; Alkaline Phosphatase; Blood Chemical Analysis; Bone and Bones; Bone Development; | 1968 |
[Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Hypophysectomy; Middl | 1968 |
Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Carcinoma; Chemistry, | 1968 |
[Measurement of collagen metabolism in the diagnosis of bone metastases].
Topics: Aged; Bone Neoplasms; Collagen; Female; Humans; Hydroxyproline; Male; Methods; Middle Aged; Neoplasm | 1969 |
Urinary hydroxyproline excretion in patients with cancer.
Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; Creatine; Female; Humans; | 1969 |
Hydroxyproline excretion in malignant neoplastic disease.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Carcinoma, Bronchogenic; Female | 1966 |
Urinary hydroxyproline and calcium metabolism in patients with cancer.
Topics: Bone Neoplasms; Calcium; Humans; Hydroxyproline; Hypercalcemia; Neoplasm Metastasis; Neoplasms; Urin | 1966 |
[Hydroxyproline excretion as an index for the evaluation of metabolic bone changes].
Topics: Adult; Animals; Bone Neoplasms; Breast Neoplasms; Child; Female; Humans; Hydroxyproline; Metabolic D | 1966 |
[On the excretion of bound hydroxyproline as an expression of changes in the organic cartilage and bone matrix].
Topics: Adolescent; Bone and Bones; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Cartilage; Ehlers-Danlo | 1966 |